EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Proton-pump inhibitor-induced severe hypomagnesemia presenting with seizure and functional hypoparathyroidism: A diagnostic challenge in long-term acid suppression therapy

Yasir Hassan, Gampa Sarjanya, Jegan Duraiswamy, Prabu Ram

Indian Journal of Pharmacology · 2026-11 · 58 (6) · 791-793

DOI: 10.4103/ijp.ijp_278_26 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Indian Journal of Pharmacology, online erschienen am 02.11.2026. Verfasst von Yasir Hassan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, D Y Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Omeprazole, Hypoparathyroidism, Seizures. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proton-pump inhibitors (PPIs) are popular drugs used to treat acid-related disorders. The PPIs, though effective and relatively safe, have been linked to clinically significant hypomagnesemia with long-term use, which causes potentially life-threatening complications. A 68-year-old male with an 8-year history of omeprazole 40 mg/day use presented with a generalized tonic–clonic seizure and neuromuscular irritability. Laboratory tests showed severe hypomagnesemia (0.32 mmol/L), hypocalcemia (corrected calcium 1.62 mmol/L), hypokalaemia (3.2 mmol/L), and low parathyroid hormone (12 pg/mL). 24-h urine magnesium was low (12 mg/day), suggesting external magnesium loss. Serum Vitamin D levels and renal function tests were within normal limits. Electrocardiography showed Corrected QT (QTc) interval prolongation (510 ms) with ventricular ectopy. Magnesium levels failed to normalize despite intravenous replacement until omeprazole was discontinued and replaced with famotidine. PPI-induced hypomagnesemia should be suspected in patients on long-term therapy presenting with electrolyte disturbances, seizures, or arrhythmias. Recognition is crucial, as correction is often refractory until the offending drug is withdrawn.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsOmeprazoleHypoparathyroidismSeizuresMagnesium DeficiencyHumansMaleAgedMagnesium

Stichwörter der Autor:innen

Electrolyte imbalancefunctional hypoparathyroidismhypomagnesemiaomeprazoleproton pump inhibitorstransient receptor potential melastatin-6

Substanzen

Proton Pump InhibitorsOmeprazoleMagnesium

Autor:innen und Institutionen

  • Department of Pharmacology, D Y Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.

Zitieren

APA

Hassan, Y., Sarjanya, G., Duraiswamy, J., & Ram, P. (2026). Proton-pump inhibitor-induced severe hypomagnesemia presenting with seizure and functional hypoparathyroidism: A diagnostic challenge in long-term acid suppression therapy. Indian Journal of Pharmacology, 58(6), 791-793. https://doi.org/10.4103/ijp.ijp_278_26

Vancouver

Hassan Y, Sarjanya G, Duraiswamy J, Ram P. Proton-pump inhibitor-induced severe hypomagnesemia presenting with seizure and functional hypoparathyroidism: A diagnostic challenge in long-term acid suppression therapy. Indian Journal of Pharmacology. 2026;58(6):791-793. doi:10.4103/ijp.ijp_278_26

BibTeX
@article{Hassan2026,
  author = {Hassan, Yasir and Sarjanya, Gampa and Duraiswamy, Jegan and Ram, Prabu},
  title = {Proton-pump inhibitor-induced severe hypomagnesemia presenting with seizure and functional hypoparathyroidism: A diagnostic challenge in long-term acid suppression therapy},
  journal = {Indian Journal of Pharmacology},
  year = {2026},
  volume = {58},
  number = {6},
  pages = {791--793},
  doi = {10.4103/ijp.ijp_278_26}
}
Kostenlos starten →